Articles by Eric S. Langer - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Eric S. Langer

Better Upstream Technologies

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.
Jun 1, 2011

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

Top 1000 Biomanufacturing Facilities

Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.
Jun 1, 2011

Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.

Regulatory Challenges Impede the Adoption of New Downstream Processing Technologies

Can vendor—user partnerships overcome the typical wait-and-see attitude toward new technologies?
Oct 1, 2010

Can vendor—user partnerships overcome the typical wait-and-see attitude toward new technologies?

Downstream Disposables: The Missing Link in the Disposables Chain

Although single-use systems are widely used in upstream unit operations, their acceptance in downstream processes has been slow.
Aug 1, 2010

Although single-use systems are widely used in upstream unit operations, their acceptance in downstream processes has been slow.

Will Protein A Be the Long-Term Solution for Your Purification Needs?

Biomanufacturers and vendors are now exploring more cost-effective purification technologies.
Jun 1, 2010

Biomanufacturers and vendors are now exploring more cost-effective purification technologies.

Downstream Processing: Promising Technologies are on the Horizon

The new technologies being developed to improve downstream systems go beyond traditional chromatography.
Mar 1, 2010

The new technologies being developed to improve downstream systems go beyond traditional chromatography.

Where Will Biopharma Hiring Take Place in 2013?

Jan 12, 2010

Licensing of Expression Systems

Gaining a license can be a complex process, but a few key tips can help you avoid common pitfalls and patent infringements.
Dec 1, 2009

Gaining a license can be a complex process, but a few key tips can help you avoid common pitfalls and patent infringements.

Avoiding the Regulatory Catch 22

Companies often wait for a critical mass before adopting new technologies. But if no one takes the risk, critical mass will never be reached.
Aug 1, 2009

Companies often wait for a critical mass before adopting new technologies. But if no one takes the risk, critical mass will never be reached.

ADVERTISEMENT

ADVERTISEMENT

Click here